Events

ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients. Through strong relationships with global regulatory agencies, academic institutions, and industry partners, ISCT drives the advancement of research into a standard of care.

Biosimilar medicines stand at the crossroads of access, sustainability, and industrial resilience. This year’s Biosimilar Medicines Conference programme will explore how strategic coalitions for change can emerge across value chains, geographies, and stakeholders to unlock the full potential of biosimilar medicines to deliver meaningful impact for patients, health systems and society at large.

ACCESS Forum brings together Thought Leaders, Executives, and Key Stakeholders across Market and Patient Access several times a year to engage, get smarter, problem-solve and challenge the system.

Stay informed and connected by attending the US Pharma and Biotech Summit 2025. Organized by FT Live in collaboration with Endpoints News, the event will bring together top executives, investors and experts to share powerful insights into the future of life sciences in America and worldwide.

Policy makers and payers face mounting pressure to make evidence-based decisions that balance innovation with sustainable access. The healthcare ecosystem, real-world data, health economic models, and clinical outcomes assessments continuously demonstrate their ability to generate high-quality evidence and guide these decisions. Health economics and outcomes research (HEOR) stands at the forefront, providing rigorous data, frameworks, and insights needed to demonstrate value, guide resource allocation, and shape policies that matter.

Join us in May 2026 for the third annual exclusive gathering of senior level investors, corporate executives, entrepreneurs and start-up leaders from biotech, tech bio, biomedical research, drug discovery and healthcare sectors.

By bringing together people with rare diseased and patient advocates, policy makers, healthcare industry representatives, clinicians, regulators and Member State representatives EURORDIS harnesses the power of this extensive network to shape goal-driven rare disease policies of the future.

With over 700 participants attending in 2024, the Conference represents an unrivalled opportunity to network and exchange invaluable insights within the rare disease community. Through collaborative efforts, these discussions culminate in clear policy recommendations that can influence both EU and national policies.

The World Orphan Drug Congress USA brings together the leading pharmaceutical and biotechnology companies, government and regulators, patient advocates, payers, investors, and solution providers – all who all depend on our event to convene and brainstorm ways to advance.

The London Biotech Show is Europe’s flagship biotechnology event, connecting global leaders across biotech to accelerate innovation, partnerships, and investment shaping the future of healthcare and life sciences.

GetReal® Institute is an independent, multi-stakeholder, non-profit forum that unites partners from across Europe and beyond to advance the use of real-world evidence (RWE) in healthcare decision-making

The ISPOR Healthcare Investment Summit 2026 brings together investors, drug developers, policy leaders, and value strategists to learn how products are evaluated, paid for, and adopted in an evolving policy environment. Sessions will highlight real investment challenges, surface practical insights, and strengthen connections between capital and evidence that can inform smarter, more resilient investment decisions.